Combined therapy aspirin, statins (means to reduce cholesterol) and two drugs for the correction of blood pressure, helped half the risk of death from cardiovascular diseases, found out the international team of researchers. Their work is published in The Lancet magazine.
Scientists out of 13 countries analyzed the data of three clinical studies at 18 thousand patients out of 26 countries, which had not previously been detected by cardiovascular diseases. They compared two combined drugs with a prescribed dose – one with aspirin, the other without. It turned out that the reception of the first had lowered the risk of infarction by 53 percent, the risk of stroke by 51 percent, and the risk of death from cardiovascular diseases is 49 percent. At the same time, as scientists noted, the combination has successfully acted both in a separate reception of each component and as a politablette.
“The action [of the drug] is equally at different levels of blood pressure and cholesterol, does not depend on the presence of diabetes. However, the greatest effect can be achieved by the elderly,” said the first author of the University of McMaster (Canada) Philip Joseph. According to scientists, large-scale use of the drug can help avoid stroke, heart attack and death from them from five to ten million people annually.